Patents-Review.com
🔗 Permalink
Assignee profile:

TeneoBio, Inc.

City:

Thousand Oaks, California

Country:

United States

Published Applications:

12

Last publication date:

2026-06-11

Patent Grants:

10

Last grant date:

2026-03-10

Top Inventors for applications by TeneoBio, Inc.

These are the the leading inventors for applications assigned to TeneoBio, Inc.:

Recent patent applications by TeneoBio, Inc.

TeneoBio, Inc. based in Thousand Oaks, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-06-11
US20260159566A1
Chemistry; metallurgy

ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

 #2 | 2025-07-24
US20250236681A1
Chemistry; metallurgy

HEAVY CHAIN ANTIBODIES BINDING TO PSMA

 #3 | 2024-03-21 ✅ Patent 12,570,717 granted on 2026-03-10
US20240091264A1
Human necessities

ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS

 #4 | 2024-01-18 ✅ Patent 12,590,163 granted on 2026-03-31
US20240018250A1
Chemistry; metallurgy

AGONISTIC ANTI-IL-2R ANTIBODIES AND METHODS OF USE

 #5 | 2023-08-03 ✅ Patent 11,884,735 granted on 2024-01-30
US20230242653A1
Chemistry; metallurgy

Agonistic anti-IL-2R antibodies and methods of use

 #6 | 2023-02-09 ✅ Patent 12,371,505 granted on 2025-07-29
US20230045100A1
Chemistry; metallurgy

ANTI-BCMA HEAVY CHAIN-ONLY ANTIBODIES

 #7 | 2022-06-23 ✅ Patent 12,180,298 granted on 2024-12-31
US20220195068A1
Chemistry; metallurgy

Heavy chain antibodies binding to PSMA

 #8 | 2021-05-20 ✅ Patent 11,970,540 granted on 2024-04-30
US20210147564A1
Chemistry; metallurgy

Anti-BCMA heavy chain-only antibodies

 #9 | 2021-04-01 ✅ Patent 11,873,336 granted on 2024-01-16
US20210095022A1
Chemistry; metallurgy

Heavy chain antibodies binding to CD22

 #10 | 2021-02-18 ✅ Patent 11,905,326 granted on 2024-02-20
US20210047402A1
Chemistry; metallurgy

Multispecific heavy chain antibodies binding to CD22 and CD3

 #11 | 2019-08-29 ✅ Patent 11,613,572 granted on 2023-03-28
US20190263904A1
Chemistry; metallurgy

CD3 binding antibodies

 #12 | 2019-07-25 ✅ Patent 12,495,776 granted on 2025-12-16
US20190225671A1
Chemistry; metallurgy

TRANSGENIC NON-HUMAN ANIMALS PRODUCING MODIFIED HEAVY CHAIN-ONLY ANTIBODIES

Also check out TeneoBio, Inc.'s (Thousand Oaks, United States) applicant profile with 27 patent applications submitted.

AssigneeID:

347932 ⎘